Obviously, ghostwriting pharmaceutical research studies isn’t new(s)…

“The pharmaceutical industry relies on ghost-written publications in peer-reviewed journals as part of their marketing plans,” said Fugh-Berman. “Physicians rely on information in the medical literature to make treatment decisions, so hidden sponsorship of articles—and lectures at medical conferences—is not only unethical, but can compromise patient care.”

In her commentary, Dr. Fugh-Berman reports that she was approached by a medical education company working for a well-known pharmaceutical manufacturer. The company asked her to lend her name as “author” to a completed manuscript that reviewed herb-warfarin interactions. The pharmaceutical manufacturer was developing a competitor to warfarin and had apparently commissioned the article to highlight problems with warfarin.

[via sciencedaily]

Popularity: 1% [?]